← Leaderboards
Lanlan Shen
University Of Tx Md Anderson Can Ctr
$6,924,000
Attributed
$7,332,560
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,332,560 · 8
By mechanism
R01$5,446,823 · 3
R21$1,885,737 · 5
Top collaborators
- Miaohsueh Chen2 shared
- Mohan Pammi2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Jae-Il Park$5,811,462
- Y. Alan Wang$3,748,710
- Roza Insafetdinovna Nurieva$10,025,772
Others in their field
Top investigators on “Epigenetic Process”
- James E. Gern · University Of Wisconsin-Madison$115,652,679
- Richard A Gibbs · Baylor College Of Medicine$86,065,396
- Lisa P Jacobson · Johns Hopkins University$67,179,266
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$58,922,015
- Leonardo Trasande · New York University School Of Medicine$52,109,279
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$47,855,284
Research focus
Epigenetic ProcessDna MethylationGenesMitoticMouse ModelMalignant NeoplasmsAberrant Dna MethylationMethylationGene FunctionPromoterHeritabilityDesignPathway InteractionsMolecularOrganoidsIn VivoTumor Suppressor GenesGene SilencingPublishingTumorBaseTumorigenesisDemethylationPattern
Grant awards (28)
Developing mouse models for functional studies of locus-specific DNA methylation$395,450
R21 · FY2025 · OD · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$394,591
R01 · FY2025 · CA · contact PI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy$360,667
R01 · FY2025 · CA · contact PI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy$342,634
R01 · FY2024 · CA · contact PI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy$353,455
R01 · FY2023 · CA · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$350,851
R01 · FY2023 · CA · contact PI
Early Environment, Developmental Epigenetics, and Adult Colonic Diseases$304,557
R01 · FY2023 · HD · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$350,851
R01 · FY2022 · CA · contact PI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy$349,064
R01 · FY2022 · CA · contact PI
Early Environment, Developmental Epigenetics, and Adult Colonic Diseases$304,557
R01 · FY2022 · HD · contact PI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy$365,308
R01 · FY2021 · CA · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$358,011
R01 · FY2021 · CA · contact PI
Early Environment, Developmental Epigenetics, and Adult Colonic Diseases$304,557
R01 · FY2021 · HD · contact PI
Microbiome Induced Epigenetic Changes in Intestinal Inflammation and Necrotizing Enterocolitis$190,762
R21 · FY2021 · HD
Regulation and function of developmentally programmed 3 CpG island methylation$179,750
R21 · FY2021 · HD · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$125,417
R01 · FY2021 · CA · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$358,011
R01 · FY2020 · CA · contact PI
Early Environment, Developmental Epigenetics, and Adult Colonic Diseases$310,773
R01 · FY2020 · HD · contact PI
Microbiome Induced Epigenetic Changes in Intestinal Inflammation and Necrotizing Enterocolitis$230,908
R21 · FY2020 · HD
Regulation and function of developmentally programmed 3 CpG island methylation$215,700
R21 · FY2020 · HD · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$122,508
R01 · FY2020 · CA · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$33,000
R01 · FY2020 · CA · contact PI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis$358,011
R01 · FY2019 · CA · contact PI
Targeting aberrant promoter DNA methylation for anticancer therapy$147,682
R21 · FY2019 · CA · contact PI
Targeting aberrant promoter DNA methylation for anticancer therapy$182,700
R21 · FY2018 · CA · contact PI
Massively Parallel Sequencing Technology for Cancer Epigenome.$173,385
R21 · FY2010 · CA · contact PI
Massively Parallel Sequencing Technology for Cancer Epigenome.$109,317
R21 · FY2009 · CA · contact PI
Massively Parallel Sequencing Technology for Cancer Epigenome.$60,083
R21 · FY2009 · CA · contact PI